Lupus-like syndromes induced by drugs.
D000974:Antibodies, Antinuclear / Q000032:analysis; D000917:Antibody Formation; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002746:Chlorpromazine / Q000009:adverse effects; D004277:DNA, Single-Stranded; D064420:Drug-Related Side Effects and Adverse Reactions; D005189:False Positive Reactions; D005260:Female; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007519:Isoantigens; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000188:drug therapy / Q000235:genetics; D008213:Lymphocyte Activation; D008297:Male; D009504:Neutrophils; D009698:Nucleoproteins; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D012075:Remission, Spontaneous; D013588:Syphilis Serodiagnosis
D000974:Antibodies, Antinuclear; D004277:DNA, Single-Stranded; D005938:Glucocorticoids; D007519:Isoantigens; D009698:Nucleoproteins; D006830:Hydralazine; D010672:Phenytoin; D010396:Penicillamine; D011342:Procainamide; D002746:Chlorpromazine; D007538:Isoniazid